OK-432 therapy for lymphangioma in children: Why and how does it work?

Intracystic injection of OK-432: A new sclerosing therapy for cystic hygroma in children

S Ogita, T. Tsuto, K. Tokiwa et al. · British journal of surgery · 1987 · 278 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +9

OK-432 therapy in 64 patients with lymphangioma

Shuhei Ogita, T. Tsuto, Kaori Nakamura et al. · Journal of Pediatric Surgery · 1994 · 215 citations

Veterinary Medicine, Immunology, Oncology +4

OK-432 therapy for unresectable lymphangiomas in children

Shuhei Ogita, T. Tsuto, Eiichi Deguchi et al. · Journal of Pediatric Surgery · 1991 · 163 citations

Medicine, Oncology, Pediatrics +7

New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.

Motomichi Torisu, Mitsuo Katano, Yutaka Kimura et al. · PubMed · 1983 · 162 citations

Life Sciences, Immunology, Infectious Diseases +3

Clinical studies on cell-mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsivenessin vitro

Takashi Hoshino · Cancer · 1980 · 159 citations

Life Sciences, Immunology, Oncology +15